W355 bil. anti-inflammatory & analgesic agents market warms up

Published: 2008-10-10 07:00:00

Updated: 2008-10-10 07:00:00

The competitive 355 billion won market for anti-inflammatory & analgesic drugs is set to heat up as Daewon Pharm is rushing into the game selling its homegrown Peluvi tablets (felubiprofen) at hospitals nationwide.

The local anti-inflammatory & analgesic medicines market has seen 5-10 percent ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK